News
We send the latest information from SMC Laboratories.
Announcement of webinar 【Creating high quality non-clinical study designs based on clinical trials】
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on February 1…
Introduction of positive control drug for kidney fibrosis mouse model
Today, we would like to introduce an established positive control – an ALK5 inhibitor – for our Un…
Introduction of our experiences in histopathological analyses for IPF
Today, we present some new histopathological data from our bleomycin-induced pulmonary fibrosis model, which i…
February 4th is World Cancer Day!
World Cancer Day was established on February 4th, 2000, at the World Summit Against Cancer for the New Millenn…
Study on the efficacy of dietary supplements in the mdx mouse published in bioRxiv.
SMC is proud to announce that GN Corporation (JPN) has published the results of their study using our pre-clin…
SMC announces Announcement of webinar 【High quality non-clinical study designs】
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place next week on …
NASH, the fastest growing cause of liver cancer
We wish you a Happy and Prosperous New Year! If you are currently planning to begin a project this year, we wo…
SMC to attend Japan-UK Virtual Partnering!
We are pleased to announce that SMC Laboratories will be participating in the Japan-UK Virtual Partnering Onli…
Fibrosis is involved in many diseases and disease-related deaths
Today's topic is Fibrosis. We would like to discuss with you the importance of therapeutic treatments tha…
Study on the efficacy of dietary supplements in the STAM™ model published in Cell Death & Disease.
SMC is proud to announce that J2H biotech (KOR) has published the results of their study using our pre-clinica…